Impact of Avène Thermal Spring Water on immune cells.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
13
02
2020
accepted:
26
02
2020
entrez:
2
9
2020
pubmed:
2
9
2020
medline:
30
4
2021
Statut:
ppublish
Résumé
The hydrotherapy centre in Avène, France, is used extensively to treat inflammatory skin diseases. Nevertheless, the immune mechanisms targeted by Avène Thermal Spring Water (TSW) are not fully understood. Here, we review the main results reported regarding the effects of Avène TSW on the immune system. In particular, mast cells, dendritic cells (DCs) and CD4
Substances chimiques
Mineral Waters
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
21-26Informations de copyright
© 2020 European Academy of Dermatology and Venereology.
Références
Matz H, Orion E, Wolf R. Balneotherapy in dermatology. Dermatol Ther 2003; 16: 132-140.
Merial-Kieny C, Mengual X, Guerrero D, Sibaud V. Clinical efficacy of Avene hydrotherapy measured in a large cohort of more than 10,000 atopic or psoriatic patients. J Eur Acad Dermatol Venereol 2011; 25(Suppl 1): 30-34.
Dainichi T, Kitoh A, Otsuka A et al. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol 2018; 19: 1286-1298.
Bjerre RD, Bandier J, Skov L, Engstrand L, Johansen JD. The role of the skin microbiome in atopic dermatitis: a systematic review. Br J Dermatol 2017; 177: 1272-1278.
Silverberg JI, Kantor R. The role of interleukins 4 and/or 13 in the pathophysiology and treatment of atopic dermatitis. Dermatol Clin 2017; 35: 327-334.
Weidinger S, Novak N. Atopic dermatitis. Lancet (London, England) 2016; 387: 1109-1122.
Beck LA, Thaci D, Hamilton JD et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 2014; 371: 130-139.
Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol 2017; 140: 645-653.
Boehncke W-H, Schön MP. Psoriasis. Lancet 2015; 386: 983-994.
Schön MP. Adaptive and innate immunity in psoriasis and other inflammatory disorders. Front Immunol 2019; 10.
Erichsen CY, Jensen P, Kofoed K. Biologic therapies targeting the IL-23/IL-17 immune axis for the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2019;34: 30-38.
Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol 2014; 32: 227-255.
Haniffa M, Gunawan M, Jardine L. Human skin dendritic cells in health and disease. J Dermatol Sci 2015; 77: 85-92.
Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
Collin M, McGovern N, Haniffa M. Human dendritic cell subsets. Immunology 2013; 140: 22-30.
Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3: 984-993.
Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol 2015; 16: 343.
Sabat R, Wolk K, Loyal L, Döcke W-D, Ghoreschi K. T cell pathology in skin inflammation. Semin Immunopathol 2019; 41: 359-377.
Park CO, Fu X, Jiang X et al. Staged development of long-lived T-cell receptor alphabeta TH17 resident memory T-cell population to Candida albicans after skin infection. J Allergy Clin Immunol 2018; 142: 647-662.
Wakim LM, Waithman J, van Rooijen N, Heath WR, Carbone FR. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 2008; 319: 198-202.
Gaudenzio N, Laurent C, Valitutti S, Espinosa E. Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype. J Allergy Clin Immunol 2013; 131: 1400-1407 e1411.
Metz M, Siebenhaar F, Maurer M. Mast cell functions in the innate skin immune system. Immunobiology 2008; 213: 251-260.
Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y. Mast cells in atopic dermatitis. Curr Opin Immunol 2009; 21: 666-678.
Ando T, Xiao W, Gao P et al. Critical role for mast cell Stat5 activity in skin inflammation. Cell Rep 2014; 6: 366-376.
Toruniowa B, Jablońska S. Mast cells in the initial stages of psoriasis. Arch Dermatol Res1988; 280: 189-193.
Joly F, Charveron M, Aries MF et al. Effect of Avene spring water on the activation of rat mast cell by substance P or antigen. Skin Pharmacol Appl Skin Physiol 1998; 11: 111-116.
Joly F, Galoppin L, Bordat P, Cousse H, Neuzil E. Calcium and bicarbonate ions mediate the inhibition of mast cell histamine release by Avene spa water. Fundam Clin Pharmacol 2000; 14: 611-613.
Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol 2014; 14: 478-494.
Jarvikallio A, Harvima IT, Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003; 295: 2-7.
Sugiura H, Maeda T, Uehara M. Mast cell invasion of peripheral nerve in skin lesions of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992; 176: 74-76.
Eliasse Y, Galliano MF, Redoules D, Espinosa E. Effect of thermal spring water on human dendritic cell inflammatory response. J Inflamm Res 2019; 12: 181-194.
Tang-Huau TL, Segura E. Human in vivo-differentiated monocyte-derived dendritic cells. Semin Cell Dev Biol 2019; 86: 44-49.
Hespel C, Moser M. Role of inflammatory dendritic cells in innate and adaptive immunity. Eur J Immunol 2012; 42: 2535-2543.
Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
Walsh KP, Mills KHG. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol 2013; 34: 521-530.
Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996; 106: 446-453.
Zaba LC, Fuentes-Duculan J, Eungdamrong NJ et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 2009; 129: 79-88.
Raker VK, Domogalla MP, Steinbrink K. Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man. Front Immunol 2015; 6.
Schülke S. Induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses. Front Immunol 2018; 9.
Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28: 445-489.
Portales P, Aries MF, Licu D et al. Immunomodulation induced by Avene spring water on Th1- and Th2-dependent cytokine production in healthy subjects and atopic dermatitis patients. Skin Pharmacol Appl Skin Physiol 2001; 14: 234-242.
Schulke S. Induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses. Front Immunol 2018; 9: 455.
Volz T, Skabytska Y, Guenova E et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol 2014; 134: 96-104.
Taieb C, Sibaud V, Merial-Kieny C. Impact of Avene hydrotherapy on the quality of life of atopic and psoriatic patients. J Eur Acad Dermatol Venereol 2011; 25(Suppl 1): 24-29.
Martin H, Laborel-Preneron E, Fraysse F et al. Aquaphilus dolomiae extract counteracts the effects of cutaneous S. aureus secretome isolated from atopic children on CD4(+) T cell activation. Pharm Biol 2016; 54: 2782-2785.
Aries MF, Hernandez-Pigeon H, Vaissiere C et al. Anti-inflammatory and immunomodulatory effects of Aquaphilus dolomiae extract on in vitro models. Clin Cosmet Investig Dermatol 2016; 9: 421-434.
Kubinak JL, Round JL. Toll-like receptors promote mutually beneficial commensal-host interactions. PLoS Pathog 2012; 8: e1002785-e1002785.